CN112155143A - 一种具有护肤养颜功能的速溶固体饮料及其制备方法 - Google Patents
一种具有护肤养颜功能的速溶固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN112155143A CN112155143A CN202011096773.6A CN202011096773A CN112155143A CN 112155143 A CN112155143 A CN 112155143A CN 202011096773 A CN202011096773 A CN 202011096773A CN 112155143 A CN112155143 A CN 112155143A
- Authority
- CN
- China
- Prior art keywords
- parts
- solid beverage
- roselle
- angelica
- cistanche
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 26
- 239000007787 solid Substances 0.000 title claims abstract description 23
- 230000003796 beauty Effects 0.000 title claims description 15
- 238000002360 preparation method Methods 0.000 title claims description 8
- 239000003814 drug Substances 0.000 claims abstract description 30
- 230000006870 function Effects 0.000 claims abstract description 30
- 240000004153 Hibiscus sabdariffa Species 0.000 claims abstract description 23
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 claims abstract description 23
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 22
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims abstract description 21
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims abstract description 21
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims abstract description 21
- 235000006533 astragalus Nutrition 0.000 claims abstract description 21
- 235000021014 blueberries Nutrition 0.000 claims abstract description 21
- 241000213006 Angelica dahurica Species 0.000 claims abstract description 20
- 240000000851 Vaccinium corymbosum Species 0.000 claims abstract description 20
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 19
- 241000005787 Cistanche Species 0.000 claims abstract description 19
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 19
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 18
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 15
- 241000220317 Rosa Species 0.000 claims abstract description 15
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 240000000249 Morus alba Species 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 244000269722 Thea sinensis Species 0.000 claims description 24
- 239000000463 material Substances 0.000 claims description 20
- 239000007788 liquid Substances 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 16
- 238000002791 soaking Methods 0.000 claims description 16
- 244000077995 Coix lacryma jobi Species 0.000 claims description 11
- 241000576429 Forsythia suspensa Species 0.000 claims description 10
- 241000218231 Moraceae Species 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 8
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 241000109329 Rosa xanthina Species 0.000 claims description 7
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 241000555712 Forsythia Species 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 239000004615 ingredient Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 229940098458 powder spray Drugs 0.000 claims description 4
- 238000001694 spray drying Methods 0.000 claims description 4
- 235000007297 Gaultheria procumbens Nutrition 0.000 claims description 3
- 241000169546 Lycium ruthenicum Species 0.000 claims description 3
- 239000006104 solid solution Substances 0.000 claims 2
- 240000001238 Gaultheria procumbens Species 0.000 claims 1
- 244000182216 Mimusops elengi Species 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 4
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 241000555682 Forsythia x intermedia Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 235000013616 tea Nutrition 0.000 description 20
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000003734 kidney Anatomy 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 230000010415 tropism Effects 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 230000009471 action Effects 0.000 description 8
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- 240000002624 Mespilus germanica Species 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 229960001948 caffeine Drugs 0.000 description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 244000061520 Angelica archangelica Species 0.000 description 3
- 241001061264 Astragalus Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000004130 lipolysis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 201000009240 nasopharyngitis Diseases 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000004233 talus Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001635574 Sabatia angularis Species 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 206010040925 Skin striae Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000000916 dilatatory effect Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- OLOOJGVNMBJLLR-UHFFFAOYSA-N imperatorin Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OCC=C(C)C OLOOJGVNMBJLLR-UHFFFAOYSA-N 0.000 description 2
- XKVWLLRDBHAWBL-UHFFFAOYSA-N imperatorin Natural products CC(=CCOc1c2OCCc2cc3C=CC(=O)Oc13)C XKVWLLRDBHAWBL-UHFFFAOYSA-N 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- QTAGQHZOLRFCBU-CYBMUJFWSA-N (+)-oxypeucedanin Chemical compound CC1(C)O[C@@H]1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-CYBMUJFWSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 description 1
- 240000000559 Albizia odoratissima Species 0.000 description 1
- 235000011438 Albizia odoratissima Nutrition 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000336291 Cistanche deserticola Species 0.000 description 1
- 241000336315 Cistanche salsa Species 0.000 description 1
- 240000007371 Cuscuta campestris Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- QTAGQHZOLRFCBU-UHFFFAOYSA-N Oxypeucadanin Natural products CC1(C)OC1COC1=C(C=CO2)C2=CC2=C1C=CC(=O)O2 QTAGQHZOLRFCBU-UHFFFAOYSA-N 0.000 description 1
- NUCBCBCPICFGMZ-UHFFFAOYSA-N Oxypeucedanin Natural products CC1(C)OC1COC1=CC(=O)OC2=C1C=C1C=COC1=C2 NUCBCBCPICFGMZ-UHFFFAOYSA-N 0.000 description 1
- MWEVYJRFLDKUCW-UHFFFAOYSA-N Oxypeucedonin-hydrat Natural products CC(C)(O)C(O)Cc1c2C=CC(=O)Oc2cc3occc13 MWEVYJRFLDKUCW-UHFFFAOYSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 241000913745 Spatholobus Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- PCWZKQSKUXXDDJ-UHFFFAOYSA-N Xanthotoxin Natural products COCc1c2OC(=O)C=Cc2cc3ccoc13 PCWZKQSKUXXDDJ-UHFFFAOYSA-N 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010064930 age-related macular degeneration Diseases 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229960004469 methoxsalen Drugs 0.000 description 1
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- HRWVKZXRZVVBLP-UHFFFAOYSA-N oxypeucedanin hydrate Natural products CC(C)(O)C(O)CCc1c2C=CC(=O)Oc2cc3occc13 HRWVKZXRZVVBLP-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有护肤养颜功能的速溶固体饮料,包括以下重量份数的成分:黑枸杞8‑12份、玫瑰茄9‑13份、黄芪3‑6份、薏苡仁4‑7份、肉苁蓉3‑7份、桑葚3‑9份、当归2‑8份、玫瑰花1‑9份、连翘叶2‑8份、白芷2‑8份、甜叶菊3‑7份、大红袍茶12‑18份、蓝莓15‑25份。本发明还公开了利用上述配方制作固体饮料的方法。通过使用本发明提供的固体饮料,达到了护肤养颜、延缓衰老的目的,可广泛应用于医药及功能性食品技术领域。
Description
技术领域
本发明涉及医药及功能性食品领域,具体是指一种具有护肤养颜功能的速溶固体饮料及其制备方法。
背景技术
护肤养颜属于传统中医学驻颜泽面病机范畴,是指在美容中医学基本理论指导下,采用保健食品、保健药品、保健用品以及运动、养生等多种方法,达到预防疾病,增强体质,延缓衰老,驻颜美型的目的。中医理论强调美容保健应该重视内调外辅相结合,在内调整人的阴阳气血,扶助正气,以提高机体抗病能力,防止内在的疾病,延缓衰老,在外则宜保持乐观的心态,适量运动,可局部施用中药化妆品及按摩等,固密肌腠,防止外邪入侵,如此内外结合,使人保持自然健美。现有技术中出现了一些用于保健的食品药品等,并均达到了一定的美容效果,但效果并不理想,且存在一定的副作用,而且长期服用也会使得服用者产生抗拒心理。
因此,一种能够克服上述缺点的饮料有待提出。
发明内容
针对以上问题,本发明提出了一种能够益肾健脾、补气活血的固体饮料。
本发明提供的技术方案为:
一种具有护肤养颜功能的速溶固体饮料,包括以下重量份数的成分:
黑枸杞8-12份、玫瑰茄9-13份、黄芪3-6份、薏苡仁4-7份、肉苁蓉3-7份、桑葚3-9份、当归2-8份、玫瑰花1-9份、连翘叶2-8份、白芷2-8份、甜叶菊3-7份、大红袍茶12-18份、蓝莓15-25份。
进一步地,包括以下重量份数的成分:
黑枸杞8份、玫瑰茄9份、黄芪3份、薏苡仁4份、肉苁蓉3份、桑葚3份、当归2份、玫瑰花1份、连翘叶2份、白芷2份、甜叶菊3份、大红袍茶12份、蓝莓15份。
进一步地,包括以下重量份数的成分:
黑枸杞12份、玫瑰茄13份、黄芪6份、薏苡仁7份、肉苁蓉7份、桑葚9份、当归8份、玫瑰花9份、连翘叶8份、白芷8份、甜叶菊7份、大红袍茶18份、蓝莓25份。
进一步地,包括以下重量份数的成分:
黑枸杞10份、玫瑰茄10份、黄芪5份、薏苡仁5份、肉苁蓉5份、桑葚5份、当归5份、玫瑰花5份、连翘叶5份、白芷5份、甜叶菊5份、大红袍茶15份、蓝莓20份。
本发明还提供了一种技术方案:
一种制备上述所述的具有护肤养颜功能的速溶固体饮料的方法,包括至少以下制备步骤:
S1、配料:分别取一定量的黑枸杞、玫瑰茄、黄芪、薏苡仁、肉苁蓉、桑葚、当归、玫瑰花、连翘叶、白芷、甜叶菊、大红袍茶和蓝莓放入纯净水中浸泡一段时间;
S2、超声波破壁:将浸泡后的混合物料连同浸泡后的纯净水一起放入超声波细胞破碎仪中,按照超声运行3s、停1s的方式运行15min,而后装入煎煮布袋;
S3、真空低温提取:将S2处理后的物料连同浸液一同放入真空低温煎煮浓缩煎药机内,并加入一定量的纯净水煎煮一段时间,取出药液;再加入一定量纯净水煎煮一段时间,取出布袋,并入前序煎煮液,移入浓缩锅内浓缩至药液为配料总量的一倍使用;
S4、将S3中的药液使用超细粉末喷雾干燥机制作成粉状物料;
S5、按照需要添加辅料分装。
进一步地,在S1中,浸泡的时间为30min。
进一步地,在S3中,前序煎煮时间为1小时,店加入的纯净水量为S2中所用浸泡水量的八倍;后续浸泡水量为S2中所用浸泡水量的四倍,后续煎煮时间为40min。
本发明与现有技术相比的优点在于:
通过使用本发明提供的配方制作成可服用固体饮料,达到了护肤养颜、消除面部色斑的目的,功能性强;
本发明中添加了能够改善服用口感的药物,使得长期服用的消费人群能够容易接受,满足大部分消费者的口感要求,使用范围广泛。
具体实施方式
下面对本发明做进一步的详细说明。
本发明提供的用于制作固体饮料的配方为:黑枸杞8-12份、玫瑰茄9-13份、黄芪3-6份、薏苡仁4-7份、肉苁蓉3-7份、桑葚3-9份、当归2-8份、玫瑰花1-9份、连翘叶2-8份、白芷2-8份、甜叶菊3-7份、大红袍茶12-18份、蓝莓15-25份。
根据中医理论,上述各个成分的药理如下:
1)玫瑰茄
[性味与归经]酸,凉。归肾经。
[功能与主治]具有敛肺止咳,降血压,解酒的功效。
[药理作用]具有一定的抗肌肉痉挛作用。抑制血栓的形成、减少动脉硬化;所含有的维生素C、接骨木三糖苷、柠檬酸等营养成分,有益于调节和平衡血脂,增进钙质吸收,促进消化等。玫瑰茄中含有原儿茶酸,具有较强的抑制皮肤肿瘤的效果。
2)黑枸杞子
[性味与归经]味甘微苦,性温,归肾经。
[功能与主治]具有补肾益肝的功效。主治腰膝酸软、阳痿遗精,***症等。
[药理作用]枸杞子中含有丰富的枸杞多糖、胡萝卜素、维E、硒以及黄酮类等抗氧化物质,对机体有很好的抗氧化效果,可以对抗机体多余的自由基,减轻自由基过氧化损伤从而起到延缓衰老的作用。
3)黄芪
[性味与归经]甘,微温。归肺、脾经。
[功能与主治]补气升阳,固表止汗,利水消肿,生津养中、行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便涯,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
[药理作用]本品能提高机体的免疫功能。黄芪多糖有较好的抗氧化作用,从而起到抗衰老作用。可促进淋巴细胞转化率,黄芪保护组与照射模型组相比有显著性差异(P<0.01),且能逆转SOD活性的降低,清除辐射产生的自由基从而降低MDA的含量,提高机体的防御能力,可为日晒的防护应用提供依据。能显著抑制组织MDA含量的升高和提高SOD活性,而清除氧自由基,并从超微结构上证实,其对膜性结构尚有一定保护作用。
4)连翘叶
[性味与归经]苦,微寒。归肺、心、小肠经。
[功能与主治]清热解毒,消肿散结,疏散风热。
[药理作用]可清热解毒,消痈散结,治疮痈、瘰疬。常用于外感风热、痈疡肿毒。含有丰富的维生素P,可降低血管脆性、通透性,防止溶血。
5)肉苁蓉
[性味与归经]甘、咸,温。归肾、大肠经。
[功能与主治]补肾阳,益精血,润肠通便。用于肾阳不足,精血亏虚,阳痿***,腰膝酸软,筋骨无力,肠燥便秘。
[药理作用]具有补肾壮阳的补益效果,其中含有的氨基酸,胱氨酸,维生素,矿物质等珍稀的营养都有着很大的滋补效果。多糖在其提取物种含量较高,多糖成分的免疫增强作用在肉苁蓉的强壮和补益效用中可能发挥着主要的影响。促进粪便的湿润和***,具有真正的润肠通便作用。具有补益作用的有益机制,能够起到抗衰老作用。
6)桑葚
[性味与归经]味甘、酸、性温。归心、肝、肾经。
[功能与主治]补肝益肾、养血生津。用于头晕目眩、耳鸣、血虚、头发早白等。
[药理作用]有抗氧化活性。能抑制黑色素合成限速酶—络氨酸酶的活性,从而起到美白肌肤的作用。
7)当归
[性味与归经]甘、辛,温。归肝、心、脾经。
[功能与主治]补血活血,调经止痛,润肠通便。用于血虚萎黄,眩晕心悸,***,经闭痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘。酒当归活血通经。用于经闭痛经,风湿痹痛,跌扑损伤。
[药理作用]当归对外周血管有明显的扩张作用。对二磷酸腺苷诱导的血小板聚集有显著的抑制作用。
8)甜叶菊
[性味与归经]味甘,性平。入肺、胃经。
[功能与主治]具有生津止渴,降血压之功效。主治消渴,高血压病。
9)玫瑰花
[性味与归经]甘、微苦,温。归肝、脾经。
[功能与主治]行气解郁,和血,止痛。用于肝胃气痛,食少呕恶,***,跌扑伤痛。
[药理作用]所含有的没食子酸行生物、缩合鞣质、多糖及多糖-肽复合物是其主要的抗氧化活性成分。所含的儿茶精类物质有烟酸样作用,可用于放射病的综合治疗并有抗肿瘤作用。有扩张血管作用。
10)白芷
[性味与归经]辛,温。归胃、大肠、肺经。
[功能与主治]解表散寒,祛风止痛,宣通鼻窍,燥湿止带,消肿排脓。用于感冒头痛,眉棱骨痛,鼻塞流涕,鼻鼽,鼻渊,牙痛,带下,疮疡肿痛。
[药理作用]白芷中的花椒毒素,欧前胡内酯和水合氧化前胡素能增强肾上腺素和ATCH所诱导的脂肪分解,抑制胰岛素诱导的由葡萄糖转化为脂肪的作用,从而间接促进脂肪的分解和抑制脂肪的合成。白芷中的呋喃香豆索类成分可用于光化学疗法治疗银屑病.白芷在体外对大肠埃希氏菌宋氏和福氏痢疾杆菌变形杆菌、伤寒和副伤寒杆菌、铜绿假单胞菌等有不同程度的抑制作用。白芷及白芷有效成分欧前胡素均可抑制毒激素-L诱导的脂肪分解反应,从而阻遏肿痛恶病质的发生发展。
11)大红袍茶
[药理作用]茶叶的咖啡碱能兴奋中枢神经***,帮助人们振奋精神、增进思维、消除疲劳、提高工作效率。茶叶中的咖啡碱和茶碱具有利尿作用,用于治疗水肿、水滞瘤。利用红茶糖水的解毒、利尿作用能治疗急性黄疸型肝炎。咖啡碱具有强心、解痉、松弛平滑肌的功效,能解除支气管痉挛,促进血液循环,是治疗支气管哮喘、止咳化痰、心肌梗塞的良好辅助药物。茶叶中的茶多酚和维生素C都有活血化瘀防止动脉硬化的作用。所以经常饮茶的人当中,高血压和冠心病的发病率较低。茶中的茶多酚和鞣酸作用于细菌,能凝固细菌的蛋白质,将细菌杀死。可用于治疗肠道疾病,如霍乱、伤寒、痢疾、肠炎等。皮肤生疮、溃烂流脓,外伤破了皮,用浓茶冲洗患处,有消炎杀菌作用。口腔发炎、溃烂、咽喉肿痛,用茶叶来治疗,也有一定疗效。茶中的咖啡碱、肌醇、叶酸、泛酸和芳香类物质等多种化合物,能调节脂肪代谢。
12)蓝莓
[性味与归经]甜酸。
[功能与主治]有效降低胆固醇,防止动脉粥样硬化,促进心血管健康;有增强心脏功能、预防癌症和心脏病的功效,能防止脑神经衰老、增强脑力;可以强化视力,减轻眼球疲劳。此外,蓝莓还可以治疗一般的伤风感冒、咽喉疼痛以及腹泻等症。
[药理作用]保护视力,可使老年性黄斑变性危险降低38%。蓝莓中水溶性膳食纤维可以促进肠道蠕动,防治便秘。含有的抗氧化剂远远多于其他新鲜蔬菜水果。抗氧化剂可中和体内自由基,增强免疫***。
本发明重在调理肺脾肾之功能,方中以黑枸杞为君药,重在益肾;臣药用玫瑰茄和薏苡仁健脾;黄芪、桑葚、肉苁蓉滋补肺肾;佐药以玫瑰花理气,当归活血,连翘叶清热解毒;使药白芷引药上行,气血畅通,腠理顺达,皮毛润泽,故能护肤养颜。
现代医学检测黄芪多糖和当归提取物含有抗氧化、清除自由基活性成分,能延缓衰老。黑枸杞、玫瑰茄含有丰富的花青素有美容作用。为了改善本发明提出的用于护肤养颜的速溶固体饮料的感官性状,配方中还根据物料的药物性能加入相应的甜叶菊、大红袍茶和冻干水果干,既克服了存在药味重的不足,还体现出独特的水果风味,便于不同味蕾人群接受。
采用上述配方制作固体饮料的方法为:
S1、配料:分别取一定量的黑枸杞、玫瑰茄、黄芪、薏苡仁、肉苁蓉、桑葚、当归、玫瑰花、连翘叶、白芷、甜叶菊、大红袍茶和蓝莓放入纯净水中浸泡一段时间;
S2、超声波破壁:将浸泡后的混合物料连同浸泡后的纯净水一起放入超声波细胞破碎仪中,按照超声运行3s、停1s的方式运行15min,而后装入煎煮布袋;
S3、真空低温提取:将S2处理后的物料连同浸液一同放入真空低温煎煮浓缩煎药机内,并加入一定量的纯净水煎煮一段时间,取出药液;再加入一定量纯净水煎煮一段时间,取出布袋,并入前序煎煮液,移入浓缩锅内浓缩至药液为配料总量的一倍使用;
S4、将S3中的药液使用超细粉末喷雾干燥机制作成粉状物料;
S5、按照需要添加辅料分装。
其中,在S1中,浸泡的时间为30min;在S3中,前序煎煮时间为1小时,店加入的纯净水量为S2中所用浸泡水量的八倍;后续浸泡水量为S2中所用浸泡水量的四倍,后续煎煮时间为40min。
实施例一
一种具有护肤养颜功能的速溶固体饮料,包括以下重量份数的成分:
黑枸杞8份、玫瑰茄9份、黄芪3份、薏苡仁4份、肉苁蓉3份、桑葚3份、当归2份、玫瑰花1份、连翘叶2份、白芷2份、甜叶菊3份、大红袍茶12份、蓝莓15份。
制备方法如下:
S1、配料:分别取一定量的黑枸杞、玫瑰茄、黄芪、薏苡仁、肉苁蓉、桑葚、当归、玫瑰花、连翘叶、白芷、甜叶菊、大红袍茶和蓝莓放入纯净水中浸泡30min;
S2、超声波破壁:将浸泡后的混合物料连同浸泡后的纯净水一起放入超声波细胞破碎仪中,按照超声运行3s、停1s的方式运行15min,而后装入煎煮布袋;
S3、真空低温提取:将S2处理后的物料连同浸液一同放入真空低温煎煮浓缩煎药机内,并加入八倍量的纯净水煎煮1小时,取出药液;再加入四倍量纯净水煎煮40min,取出布袋,并入前序煎煮液,移入浓缩锅内浓缩至药液为配料总量的一倍使用;
S4、将S3中的药液使用超细粉末喷雾干燥机制作成粉状物料;
S5、按照需要添加辅料分装。
实施例二
一种具有护肤养颜功能的速溶固体饮料,包括以下重量份数的成分:
黑枸杞12份、玫瑰茄13份、黄芪6份、薏苡仁7份、肉苁蓉7份、桑葚9份、当归8份、玫瑰花9份、连翘叶8份、白芷8份、甜叶菊7份、大红袍茶18份、蓝莓25份。
其制备方法与实施例一相同。
实施例三
一种具有护肤养颜功能的速溶固体饮料,包括以下重量份数的成分:
黑枸杞10份、玫瑰茄10份、黄芪5份、薏苡仁5份、肉苁蓉5份、桑葚5份、当归5份、玫瑰花5份、连翘叶5份、白芷5份、甜叶菊5份、大红袍茶15份、蓝莓20份。
其制备方法与实施例一相同。
实施例四
在本实施例中,对本发明的效果进行实际验证。
(1)方剂筛选
1号方剂:玫瑰花15份、玫瑰茄15份、何首乌10份、枸杞子10份、菟丝子5份、合欢花5份、鸡血藤5份、黑枸杞5份、龙眼肉10份、无花果15份、甜叶菊5份、红茶30份。
2号方剂:玫瑰茄15份、黑枸杞10份、黄芪5份、肉苁蓉5份、当归5份、菟丝子5份、薏苡仁5份、何首乌5份、甜叶菊5份、玫瑰花5份、白芷5份、冻干菠萝20份、蓝莓10份、大红袍茶30份。
3号方剂:黑枸杞10份、玫瑰茄10份、黄芪5%份、薏苡仁5份、肉苁蓉5份、桑葚5份、当归5份、玫瑰花5份、连翘叶5份、白芷5份、甜叶菊5份、大红袍茶15份、蓝莓20份。
(2)感官测评
三种方剂的感官测评
方剂编号 | 溶出速度 | 色泽 | 清澈度 | 气味及口感 |
1号方剂 | 5分钟 | 淡玫瑰红 | 较清澈 | 有明显药味 |
2号方剂 | 4分钟 | 淡褐玫瑰红 | 较清澈 | 有明显药味 |
3号方剂 | 5分钟 | 淡褐玫瑰红 | 较清澈 | 清香气、有轻微药味 |
测评结果显示:3个方剂的溶出速度、色泽、清澈度没有明显差别,但是因为1号方剂和2号方剂有明显药味,且含有普通食品不允许添加的成分,故确定用3号方剂。
(3)效果测评
因为观察延缓皮肤衰老的效果,需要比较漫长的时间,但是,本发明配方在区域医院已临床应用多年,使用者反映效果显著。
以上对本发明及其实施方式进行了描述,这种描述没有限制性。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的实施例,均应属于本发明的保护范围。
Claims (7)
1.一种具有护肤养颜功能的速溶固体饮料,其特征在于,包括以下重量份数的成分:
黑枸杞8-12份、玫瑰茄9-13份、黄芪3-6份、薏苡仁4-7份、肉苁蓉3-7份、桑葚3-9份、当归2-8份、玫瑰花1-9份、连翘叶2-8份、白芷2-8份、甜叶菊3-7份、大红袍茶12-18份、蓝莓15-25份。
2.根据权利要求1所述的一种具有护肤养颜功能的速溶固体饮料,其特征在于,包括以下重量份数的成分:
黑枸杞8份、玫瑰茄9份、黄芪3份、薏苡仁4份、肉苁蓉3份、桑葚3份、当归2份、玫瑰花1份、连翘叶2份、白芷2份、甜叶菊3份、大红袍茶12份、蓝莓15份。
3.根据权利要求1所述的一种具有护肤养颜功能的速溶固体饮料,其特征在于,包括以下重量份数的成分:
黑枸杞12份、玫瑰茄13份、黄芪6份、薏苡仁7份、肉苁蓉7份、桑葚9份、当归8份、玫瑰花9份、连翘叶8份、白芷8份、甜叶菊7份、大红袍茶18份、蓝莓25份。
4.根据权利要求1所述的一种具有护肤养颜功能的速溶固体饮料,其特征在于,包括以下重量份数的成分:
黑枸杞10份、玫瑰茄10份、黄芪5份、薏苡仁5份、肉苁蓉5份、桑葚5份、当归5份、玫瑰花5份、连翘叶5份、白芷5份、甜叶菊5份、大红袍茶15份、蓝莓20份。
5.一种制备权利要求1-4任一项所述的具有护肤养颜功能的速溶固体饮料的方法,其特征在于,包括至少以下制备步骤:
S1、配料:分别取一定量的黑枸杞、玫瑰茄、黄芪、薏苡仁、肉苁蓉、桑葚、当归、玫瑰花、连翘叶、白芷、甜叶菊、大红袍茶和蓝莓放入纯净水中浸泡一段时间;
S2、超声波破壁:将浸泡后的混合物料连同浸泡后的纯净水一起放入超声波细胞破碎仪中,按照超声运行3s、停1s的方式运行15min,而后装入煎煮布袋;
S3、真空低温提取:将S2处理后的物料连同浸液一同放入真空低温煎煮浓缩煎药机内,并加入一定量的纯净水煎煮一段时间,取出药液;再加入一定量纯净水煎煮一段时间,取出布袋,并入前序煎煮液,移入浓缩锅内浓缩至药液为配料总量的一倍使用;
S4、将S3中的药液使用超细粉末喷雾干燥机制作成粉状物料;
S5、按照需要添加辅料分装。
6.根据权利要求5所述的制备固溶饮料的方法,其特征在于,在S1中,浸泡的时间为30min。
7.根据权利要求5所述的制备固溶饮料的方法,其特征在于,在S3中,前序煎煮时间为1小时,店加入的纯净水量为S2中所用浸泡水量的八倍;后续浸泡水量为S2中所用浸泡水量的四倍,后续煎煮时间为40min。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011096773.6A CN112155143A (zh) | 2020-10-14 | 2020-10-14 | 一种具有护肤养颜功能的速溶固体饮料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011096773.6A CN112155143A (zh) | 2020-10-14 | 2020-10-14 | 一种具有护肤养颜功能的速溶固体饮料及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112155143A true CN112155143A (zh) | 2021-01-01 |
Family
ID=73868210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011096773.6A Pending CN112155143A (zh) | 2020-10-14 | 2020-10-14 | 一种具有护肤养颜功能的速溶固体饮料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112155143A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114009645A (zh) * | 2021-10-20 | 2022-02-08 | 哈尔滨健领医疗科技有限公司 | 一种美容养颜固体饮料及其制备方法 |
CN115444086A (zh) * | 2022-09-23 | 2022-12-09 | 浙江中医药大学 | 一种具有美白亮肤功能的保健饮料及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435867A (zh) * | 2013-09-17 | 2015-03-25 | 李少洋 | 一种美容养颜的中药液及其方法 |
-
2020
- 2020-10-14 CN CN202011096773.6A patent/CN112155143A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104435867A (zh) * | 2013-09-17 | 2015-03-25 | 李少洋 | 一种美容养颜的中药液及其方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114009645A (zh) * | 2021-10-20 | 2022-02-08 | 哈尔滨健领医疗科技有限公司 | 一种美容养颜固体饮料及其制备方法 |
CN115444086A (zh) * | 2022-09-23 | 2022-12-09 | 浙江中医药大学 | 一种具有美白亮肤功能的保健饮料及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103906526B (zh) | 利用药用花的包裹发酵方法及利用其的皮肤外用剂组合物 | |
CN104397227A (zh) | 一种美容养颜茶及其制备方法 | |
CN105853291A (zh) | 一种中草药洗发水 | |
CN101658618B (zh) | 一种解酒护肝复方制剂及应用 | |
CN112155143A (zh) | 一种具有护肤养颜功能的速溶固体饮料及其制备方法 | |
CN104116672A (zh) | 一种复方天然面膜及其制备方法 | |
CN106343091A (zh) | 一种减肥瘦身茶凉茶饮料及其制备方法 | |
CN105725114A (zh) | 一种刺梨复合功能保健品及其制备方法和应用 | |
CN105532991A (zh) | 一种具有养颜美容功能的复合黑茶及其制备方法 | |
CN105288597A (zh) | 一种治疗皮肤色素沉着的药物 | |
CN107518132A (zh) | 一种清肝明目花茶及其制备方法 | |
CN106417761A (zh) | 一种玫瑰养颜美人茶凉茶饮料及其制备方法 | |
CN103652845A (zh) | 一种解暑清脂养颜汤 | |
CN115227801A (zh) | 一种防脱乌发生发液、包含其的洗发水及应用 | |
CN105194487A (zh) | 一种美白养颜中药组合物及其面膜和制备方法 | |
CN104940725A (zh) | 一种养血美容的铁皮石斛中药组合物及其制剂 | |
CN110680794A (zh) | 一种纯天然无化学添加剂的食品级珍珠蜂蜜茶味口腔护理组合物的绿色制备方法及其应用 | |
CN103828974A (zh) | 一种健康减肥茶 | |
KR101058422B1 (ko) | 한방 건강 보조 식품 및 그의 제조방법 | |
CN113456752A (zh) | 一种美容组合物及其制备方法 | |
CN112870143A (zh) | 一种中药滋阴活血面膜及其制备方法 | |
CN106344480A (zh) | 一种美白祛斑无毒副作用的中药面膜及其制备方法 | |
CN106615452A (zh) | 一种杜仲保健茶及其制备方法 | |
CN112076268A (zh) | 一种防治脱发及乌发的中药洗剂及制备方法、应用 | |
KR20120009264A (ko) | 주름 및 잡티 개선용 화장료 조성물 및 이의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210101 |